No Data
No Data
Grant of Restricted Stock Units and Warrants to Employees in Genmab
H.C. Wainwright Maintains Genmab(GMAB.US) With Buy Rating, Maintains Target Price $50
Strong Sales and Robust Pipeline Reinforce Genmab's Buy Rating
Barclays Reaffirms Their Buy Rating on Genmab A/S (0MGB)
Is Genmab (GMAB) the High Growth International Stock to Invest in Now?
Express News | Genmab Shares Are Trading Lower. The Company Reported FY24 Net Sales for Darzalex